On December 4, 2017 Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, reported that Aron Knickerbocker, Chief Operating Officer, will present at the BMO Capital Markets Prescriptions for Success Healthcare Conference on Thursday, December 14, 2017 at 11:30am ET (Press release, Cellectis, DEC 4, 2017, View Source [SID1234522361]). Mr. Knickerbocker will become President and Chief Executive Officer of Five Prime on January 1, 2018.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will be webcast and may be accessed at the "Events & Presentations" section of the Company’s website at View Source or directly at https://cc.talkpoint.com/bmoc001/121417a_as/?entity=8_N6Q3JCG. Five Prime will maintain an archived replay of the webcast on its website for 30 days after the conference.